These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6163086)

  • 1. Further molecular complexities of H-2 K- and D-region antigens.
    Démant P; Iványi D
    Nature; 1981 Mar; 290(5802):146-9. PubMed ID: 6163086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. III. Reactivity of certain anti-H-2.28 alloantisera with Qa-2 antigen.
    Iványi D; Cherry M; Démant P
    Immunogenetics; 1982; 15(5):477-84. PubMed ID: 6179861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological characterization of previously unknown H-2 molecules identified in the products of the Kd and Dk region.
    Iványi D; Démant P
    Immunogenetics; 1981; 12(3-4):397-408. PubMed ID: 6162797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. II. B10.D2(M504) (H-2dm1) mutant fails to express one of the two H-2.4-, 28 + Dd region molecules.
    Iványi D; Démant P
    Immunogenetics; 1982; 15(5):467-76. PubMed ID: 6980826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2L: demonstration of four new allelic products and independence of H-2D and H-2L molecules.
    Iványi D; Snoek M; Démant P
    Tissue Antigens; 1979 Sep; 14(3):233-50. PubMed ID: 93315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of H-2 antigens.
    Démant P; Iványi D; Oudshoorn-Snoek M; Calafat J; Roos MH
    Immunol Rev; 1981; 60():5-22. PubMed ID: 6171504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of H-2L gene products in virus-immune T-cell recognition. Evidence for an H-2L-restricted T-cell response.
    Biddison WE; Hansen TH; Levy RB; Doherty PC
    J Exp Med; 1978 Dec; 148(6):1678-86. PubMed ID: 82606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Private specificity of H-2Ldx molecule detected serologically by a surface antigen redistribution method (capping).
    Ivány D; Démant P
    Tissue Antigens; 1982 Oct; 20(4):274-81. PubMed ID: 6183786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region.
    Kastner DL; Rich RR; Shen FW
    J Immunol; 1979 Sep; 123(3):1232-8. PubMed ID: 89166
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells.
    Forman J; Trial J; Tonkonogy S; Flaherty L
    J Exp Med; 1982 Mar; 155(3):749-67. PubMed ID: 6174664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different D end-dependent antigenic determinants are recognized by H-2-restricted cytotoxic T cells specific for influenza and Bebaru viruses.
    Blanden RV; Müllbacher A; Ashman RB
    J Exp Med; 1979 Jul; 150(1):166-3. PubMed ID: 87489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2K molecules have two different C-termini, one of which is K-region specific.
    Maloy WL; Lew AM; Anderson RW; Coligan JE
    Mol Immunol; 1988 May; 25(5):453-63. PubMed ID: 3412330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2.28, an alloantigenic marker allelic to H-2.1, is expressed on all three known types of H-2 molecules.
    Démant P; Iványi D; Neauport-Sautes C; Snoek M
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4441-5. PubMed ID: 81489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.